SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Menezes Eduardo F

(Last) (First) (Middle)
C/O LINDE PLC
THE PRIESTLEY CENTRE, 10 PRIESTLEY ROAD

(Street)
GUILDFORD, SURREY X0 GU2 7XY

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Head of Americas Gases Group
3. Date of Earliest Transaction (Month/Day/Year)
11/29/2018
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 11/29/2018 S 3,852.387 D $148.019 0 I 401(k)
Ordinary Shares 53,114.692 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0(1) (1) (1) Ordinary Shares 7,375 7,375 D
Restricted Stock Units $0(2) (2) (2) Ordinary Shares 6,330 6,330 D
Restricted Stock Units $0(3) (3) (3) Ordinary Shares 7,808 7,808 D
Restricted Stock Units $0(2) (2) (2) Ordinary Shares 6,464 6,464 D
Restricted Stock Units $0(3) (3) (3) Ordinary Shares 5,340 5,340 D
Stock Option (right to buy) $109.68 02/28/2013(4) 02/28/2022 Common Stock 43,005 43,005 D
Stock Option (right to buy) $110.58 02/26/2014(4) 02/26/2023 Common Stock 35,220 35,220 D
Stock Option (right to buy) $128.8 02/25/2015(4) 02/25/2024 Common Stock 37,305 37,305 D
Stock Option (right to buy) $128.38 02/24/2016(4) 02/24/2025 Common Stock 47,375 47,375 D
Stock Option (right to buy) $102.22 02/23/2017(5) 02/23/2026 Common Stock 89,070 89,070 D
Stock Option (right to buy) $118.71 02/28/2018(6) 02/28/2027 Common Stock 71,400 71,400 D
Stock Option (right to buy) $154 02/27/2019(7) 02/27/2028 Common Stock 61,430 61,430 D
Explanation of Responses:
1. Restricted Stock Units that will vest in full and payout on February 27, 2021 in Linde plc Ordinary Shares on a one-for-one basis.
2. Restricted Stock units that will vest in full and payout February 23, 2019 in Linde plc Ordinary Shares on a one-for-one basis.
3. Restricted Stock Units that will vest in full and payout on February 28, 2020 in Linde plc Ordinary Shares on a one-for-one basis.
4. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
5. This option vests over three years in three consecutive equal annual installments beginning on February 23, 2017.
6. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018.
7. This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019.
Remarks:
Anthony M. Pepper, Attorney-in-Fact 12/03/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.